FindTrial
Sign In

Analysis of risk factors for scoliosis progression in children with idiopathic short stature treated with growth hormone

Analysis of clinical characteristics of scoliosis children after growth hormone treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101112
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scoliosis

Interventions

None Progression Group:None
Progression Group:None

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: January 2021 - October 2024 All children using growth hormone with scoliosis.

Exclusion criteria

Exclusion criteria: 1.Scoliosis appeared in children prior to use of growth hormone; 2.Patients with incomplete history and follow-up records.

Design outcomes

Primary

MeasureTime frame
Cobb Angle change;—

Countries

China

Contacts

Public ContactLiu Xing

Children's Hospital of Chongqing Medical University

liuxingda@126.com+86 23 63664659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026